Literature DB >> 8102925

Polycystic ovary syndrome and psychiatric morbidity.

W Bruce-Jones1, G Zolese, P White.   

Abstract

Ten cases are reported of polycystic ovary syndrome (PCOS) in association with psychiatric illness presenting to a liaison psychiatry service. This association is critically reviewed paying attention to explanatory factors such as selection bias and steroid treatments. Monoamine imbalances may be involved in the etiology of both PCOS and the accompanying psychiatric illness.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102925     DOI: 10.3109/01674829309084434

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  4 in total

1.  Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome.

Authors:  Kiran Nandalike; Temima Strauss; Chhavi Agarwal; Susan M Coupey; Sanghun Sin; Swapnil Rajpathak; Hillel W Cohen; Raanan Arens
Journal:  J Pediatr       Date:  2011-06-08       Impact factor: 4.406

2.  A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents.

Authors:  Gideon de Sousa; Bernhard Schlüter; Dirk Buschatz; Thomas Menke; Eckardt Trowitzsch; Werner Andler; Thomas Reinehr
Journal:  Sleep Breath       Date:  2009-07-08       Impact factor: 2.816

3.  Maternal and neonatal outcomes among pregnant women with different polycystic ovary syndrome phenotypes: A cross-sectional study.

Authors:  Akramsadat Dehghani Firoozabadi; Razieh Dehghani Firouzabadi; Maryam Eftekhar; Afsar Sadat Tabatabaei Bafghi; Farimah Shamsi
Journal:  Int J Reprod Biomed       Date:  2020-05-31

4.  Psychological disturbances and quality of life in obese and infertile women and men.

Authors:  Piotr Kocełak; Jerzy Chudek; Beata Naworska; Monika Bąk-Sosnowska; Barbara Kotlarz; Monika Mazurek; Paweł Madej; Violetta Skrzypulec-Plinta; Piotr Skałba; Magdalena Olszanecka-Glinianowicz
Journal:  Int J Endocrinol       Date:  2012-07-16       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.